eF-site ID 1gzh-ABCD
PDB Code 1gzh
Chain A, B, C, D

click to enlarge
Title Crystal structure of the BRCT domains of human 53BP1 bound to the p53 tumor supressor
Classification GENE REGULATION
Compound CELLULAR TUMOR ANTIGEN P53
Source Homo sapiens (Human) (P53_HUMAN)
Sequence A:  SSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMF
CQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVR
RCPHHERCAPPQHLIRVEGLRVEYLDDRNTFRHSVVVPYE
PPECTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLL
GRNSFEVRVCACPGRDRRTEEENLRKK
B:  LNKTLFLGYAFLLTMATTSDKLASRSPPFNKQYTESQLRA
GAGYILEDFNTAYQCLLIADQHCRTRKYFLCLASGIPCVS
HVWVHDSCHANQLQNYRNYLLPAGYSLEEQRILDWQPREN
PFQNLKVLLVSDQQQNFLELWSEILMTGGAASVKQHHSSA
HNKDIALGVFDVVVTDPSCPASVLKCAEALQLPVVSQEWV
IQCLIVGERIGFKQHPKYKHDYVSH
C:  SSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMF
CQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVR
RCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRH
SVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTI
ITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLR
D:  NKTLFLGYAFLLTMATFNKQYTESQLRAGAGYILEDFNEN
TAYQCLLIADQHCRTRKYFLCLASGIPCVSHVWVHDSCHA
NQLQNYRNYLLPAGYSLEEQRILDWQPRENPFQNLKVLLV
SDQQQNFLELWSEILMTGGAASVKQHHSSAHNKDIALGVF
DVVVTDPSCPASVLKCAEALQLPVVSQEWVIQCLIVGERI
GFKQHPKYKHDYV
Description


Functional site

1) chain A
residue 176
type
sequence C
description BINDING SITE FOR RESIDUE ZN A 1293
source : AC1

2) chain A
residue 179
type
sequence H
description BINDING SITE FOR RESIDUE ZN A 1293
source : AC1

3) chain A
residue 238
type
sequence C
description BINDING SITE FOR RESIDUE ZN A 1293
source : AC1

4) chain A
residue 242
type
sequence C
description BINDING SITE FOR RESIDUE ZN A 1293
source : AC1

5) chain B
residue 1737
type
sequence T
description BINDING SITE FOR RESIDUE SO4 B 2972
source : AC2

6) chain B
residue 1738
type
sequence M
description BINDING SITE FOR RESIDUE SO4 B 2972
source : AC2

7) chain B
residue 1773
type
sequence K
description BINDING SITE FOR RESIDUE SO4 B 2972
source : AC2

8) chain B
residue 1814
type
sequence K
description BINDING SITE FOR RESIDUE SO4 B 2972
source : AC2

9) chain C
residue 183
type
sequence S
description BINDING SITE FOR RESIDUE SO4 B 2972
source : AC2

10) chain C
residue 176
type
sequence C
description BINDING SITE FOR RESIDUE ZN C 1290
source : AC3

11) chain C
residue 179
type
sequence H
description BINDING SITE FOR RESIDUE ZN C 1290
source : AC3

12) chain C
residue 238
type
sequence C
description BINDING SITE FOR RESIDUE ZN C 1290
source : AC3

13) chain C
residue 242
type
sequence C
description BINDING SITE FOR RESIDUE ZN C 1290
source : AC3

14) chain B
residue 1798
type
sequence T
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

15) chain D
residue 1736
type
sequence L
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

16) chain D
residue 1737
type
sequence T
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

17) chain D
residue 1738
type
sequence M
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

18) chain D
residue 1773
type
sequence K
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

19) chain D
residue 1814
type
sequence K
description BINDING SITE FOR RESIDUE SO4 D 2970
source : AC4

20) chain C
residue 176
type BINDING
sequence C
description BINDING => ECO:0000269|PubMed:14534297, ECO:0000269|PubMed:16793544, ECO:0000269|PubMed:17015838, ECO:0000269|PubMed:18650397, ECO:0000269|PubMed:19515728, ECO:0000269|PubMed:20142040, ECO:0000269|PubMed:20364130
source Swiss-Prot : SWS_FT_FI2

21) chain C
residue 179
type BINDING
sequence H
description BINDING => ECO:0000269|PubMed:14534297, ECO:0000269|PubMed:16793544, ECO:0000269|PubMed:17015838, ECO:0000269|PubMed:18650397, ECO:0000269|PubMed:19515728, ECO:0000269|PubMed:20142040, ECO:0000269|PubMed:20364130
source Swiss-Prot : SWS_FT_FI2

22) chain C
residue 238
type BINDING
sequence C
description BINDING => ECO:0000269|PubMed:14534297, ECO:0000269|PubMed:16793544, ECO:0000269|PubMed:17015838, ECO:0000269|PubMed:18650397, ECO:0000269|PubMed:19515728, ECO:0000269|PubMed:20142040, ECO:0000269|PubMed:20364130
source Swiss-Prot : SWS_FT_FI2

23) chain C
residue 242
type BINDING
sequence C
description BINDING => ECO:0000269|PubMed:14534297, ECO:0000269|PubMed:16793544, ECO:0000269|PubMed:17015838, ECO:0000269|PubMed:18650397, ECO:0000269|PubMed:19515728, ECO:0000269|PubMed:20142040, ECO:0000269|PubMed:20364130
source Swiss-Prot : SWS_FT_FI2

24) chain C
residue 120
type MOD_RES
sequence K
description N6-acetyllysine; by KAT6A => ECO:0000269|PubMed:23431171
source Swiss-Prot : SWS_FT_FI4

25) chain C
residue 183
type MOD_RES
sequence S
description Phosphoserine; by AURKB => ECO:0000269|PubMed:20959462
source Swiss-Prot : SWS_FT_FI5

26) chain C
residue 269
type MOD_RES
sequence S
description Phosphoserine; by AURKB => ECO:0000269|PubMed:20959462
source Swiss-Prot : SWS_FT_FI5

27) chain C
residue 284
type MOD_RES
sequence T
description Phosphothreonine; by AURKB => ECO:0000269|PubMed:20959462
source Swiss-Prot : SWS_FT_FI6

28) chain C
residue 120
type SITE
sequence K
description Interaction with DNA => ECO:0000269|PubMed:16793544, ECO:0000269|PubMed:18996393, ECO:0000269|PubMed:20364130
source Swiss-Prot : SWS_FT_FI3

29) chain A
residue 237-249
type prosite
sequence MCNSSCMGGMNRR
description P53 p53 family signature. MCNSSCMGGMNRR
source prosite : PS00348

30) chain C
residue 237-249
type prosite
sequence MCNSSCMGGMNRR
description P53 p53 family signature. MCNSSCMGGMNRR
source prosite : PS00348


Display surface

Download
Links